Manufacturer record
Deepin Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Deepin Pharmaceuticals Pvt. Ltd (Madhya Pradesh) were declared Not of Standard Quality between May 2019 and November 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 1911, Levocetrizine Tablets I.P. 5mg (exp Sep 2021). CDL Kolkata (CDSCO lab) found it not of standard quality: Description. Listed in the November 2020 alert.
Records by type
2 records linked to Deepin Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levocetrizine Tablets I.P. 5mg | Batch 1911Mfg Oct 2019 · Exp Sep 2021 | DescriptionDescription | CDL KolkataCDSCO lab | Nov 2020 |
| FURAZOLIDONE ORAL SUSPENSION IP | Batch 1803Mfg Jun 2018 · Exp May 2020 | AssayAssay | CDTL ChennaiCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.